EPISODE · May 4, 2026 · 1 MIN
Julie Rubinstein Sells Adaptive Biotech Shares
from The Daily News Now! Business
Julie Rubinstein, COO of Adaptive Biotechnologies, sold 19,037 shares, exercising 14,707 options, netting $271,000. She still holds 377,802 shares, worth $5.37M. This sale, under a Rule 10b5-1 plan, trimmed her holdings by 4.8%. Rubinsteins stake in the companys immune diagnostics tech, with growing revenue and reduced losses, suggests a positive outlook. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/71da934a331726b6
NOW PLAYING
Julie Rubinstein Sells Adaptive Biotech Shares
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m